Utah Medical Products Stock Analysis

Utah Stock Analysis Notes

About 71.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.62. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 14th of March 2025. The entity had 3:2 split on the 22nd of March 1993. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. For more information please call Kevin Cornwell at 801 566 1200 or visit https://www.utahmed.com.

Utah Medical Products Investment Alerts

Utah Medical Products Upcoming and Recent Events

Utah Largest EPS Surprises

View All Earnings Estimates

Utah Medical Environmental, Social, and Governance (ESG) Scores

Utah Medical Thematic Classifications

Utah Stock Institutional Investors

Note, although Utah Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Utah Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 190.24 M.

Utah Profitablity

The company has Profit Margin (PM) of 0.34 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.36 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.36.

Management Efficiency

Utah Medical Products has return on total asset (ROA) of 0.0762 % which means that it generated a profit of $0.0762 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1129 %, meaning that it created $0.1129 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Assets is expected to grow to 0.20, whereas Return On Tangible Assets are forecasted to decline to 0.12. At present, Utah Medical's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 101.1 M, whereas Other Current Assets are forecasted to decline to about 425.6 K.

Technical Drivers

As of the 25th of March, Utah Medical has the Coefficient Of Variation of (654.60), risk adjusted performance of (0.14), and Variance of 0.8054. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. Please validate Utah Medical Products mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 56.83 per share. Given that Utah Medical Products has information ratio of (0.12), we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.

Utah Medical Products Price Movement Analysis

Utah Medical Products Insider Trading Activities

Utah Medical Outstanding Bonds

Utah Medical Predictive Daily Indicators

Utah Medical Corporate Filings

Utah Medical Forecast Models

Utah Medical's time-series forecasting models are one of many Utah Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Utah Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Utah Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Utah shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Utah Medical. By using and applying Utah Stock analysis, traders can create a robust methodology for identifying Utah entry and exit points for their positions.

When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.